Is Mosaic Immunoengineering Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Mosaic Immunoengineering Inc (CPMV) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Mosaic Immunoengineering Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mosaic Immunoengineering Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Mosaic Immunoengineering Inc?

Muslim investors may consider investing in Mosaic Immunoengineering Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Mosaic Immunoengineering Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Mosaic Immunoengineering Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Mosaic Immunoengineering Inc updated?

The Shariah compliance status of Mosaic Immunoengineering Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Mosaic Immunoengineering Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Mosaic Immunoengineering Inc?

You can check the latest Shariah compliance status of Mosaic Immunoengineering Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Mosaic Immunoengineering Inc. Stock Analysis CPMV

United States Information Technology Nano Cap

Mosaic ImmunoEngineering, Inc. is a development-stage biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. The company is headquartered in Huntington Beach, California and currently employs 2 full-time employees. The firm is focused on new product candidates and platforms to expand its pipeline based on a deep understanding of immunotherapies and its license agreements with University of California San Diego.

Key Statistics of Mosaic Immunoengineering Inc (CPMV)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.69$0.69

Today's Open

$0.69

Volume

155.00

P/E Ratio (TTM)

52 Week Range

$0.25$1.05

Market Cap

4.73M

Avg. Volume

710.64

Dividend Yield

Financial Metrics & Statements of Mosaic Immunoengineering Inc (CPMV)

FAQ's for Mosaic Immunoengineering Inc (CPMV)

According to Musaffa’s Shariah screening methodology, Mosaic Immunoengineering Inc (CPMV) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.